Skip to main content
. 2020 Aug 28;20:291. doi: 10.1186/s12876-020-01432-7

Table 2.

Endoscopic findings, EUS features, treatment and prognosis of undiagnosed ET

CaseNo. Esophagoscopy findings EUS features Diagnostic anti- tuberculosis therapy Prognosis
1 Middle part of esophagus, protruding lesion in the mucosa 0.8 X 3.0 cm with a central ulcer 0.3 X 0.5 cm Thickening, poorly defined esophageal wall structure, enlarged para esophageal lymph nodes with scattered calcifications Isoniazid + rifampicin + pyrazinamide + ethambutol, 3 months Recovered according to endoscopy
2 Middle part of esophagus, protruding lesion in the mucosa 1.5 X 2.0 cm with a central ulcer 0.2 X 0.3 cm Thickening, poorly defined esophageal wall structure, linked to an enlarged para esophageal lymph node Isoniazid + rifampicin + pyrazinamide + ethambutol, 3 months Recovered according to endoscopy
3 Middle part of esophagus, protruding lesion in the mucosa 2.0 X 3.0 cm with a central ulcer 0.5 X 0.8 cm Thickening, poorly defined esophageal wall structure, with an enlarged para esophageal lymph node Isoniazid + rifampicin + pyrazinamide + ethambutol, 10 months Recovered according to endoscopy
4 Middle part of esophagus, protruding lesion in the mucosa 2.5 X 3.0 cm with central erosion 0.3 X 0.4 cm Thickening, poorly defined esophageal wall structure, esophageal heterogeneously hypoechoic lesion with scattered calcifications, and the hypoechoic lesion was linked to an enlarged para-esophageal lymph node Isoniazid + rifampicin + pyrazinamide + ethambutol, 5 months Recovered according to endoscopy
5 Lower part of esophagus, protruding lesion in the mucosa 1.0 X 1.5 cm with central erosion, 0.2 X 0.2 cm Thickening, poorly defined esophageal wall structure, with heterogeneously hypoechoic esophageal lesion, and interrupted partial esophageal adventitia Isoniazid + rifampicin + pyrazinamide + ethambutol, 4 months Improved according to endoscopy
6 Middle part of esophagus, submucosal bulge 0.8 X 1.0 cm with smooth surface

Thickening, poorly defined esophageal wall structure

linked to an enlarged para-esophageal lymph node, with scattered calcifications

Isoniazid + rifampicin + pyrazinamide + ethambutol, 5 months Recovered according to endoscopy
7 Upper part of esophagus, submucosal bulge 0.5 X 0.7 cm, and diverticulum Thickening, poorly defined esophageal wall structure, with enlarged para-esophageal lymph nodes Isoniazid + rifampicin + pyrazinamide + ethambutol, 9 months Improved according to endoscopy
8 Middle part of esophagus, irregular ulcer 0.3 X 0.5 cm, with fistula

Thickening, poorly defined esophageal wall structure

linked to an enlarged para-esophageal lymph node with scattered calcifications

Isoniazid + rifampicin + pyrazinamide + ethambutol, 6 months Recovered according to endoscopy
9 Middle part of esophagus, multiple ulcers 0.3 X 0.5 cm – 0.5 X 0.6 cm Thickening, poorly defined esophageal wall structure, with an enlarged para-esophageal lymph node Isoniazid + rifampicin + pyrazinamide + ethambutol, 4 months Recovered according to endoscopy